| ZYDURVIS GLAXO GROUP LIMITED
2141435 12 Jul 2021 | on 31 May 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, Hepatitis, herpes gentialis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis, pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood- related diseases and disorders, namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, depression and anxiety and their related disorders names schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy. | | | ZYBELTIS NOVO NORDISK A/S
1885618 01 Mar 2018 | on 13 Aug 2018 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of diabetes | | | ZYRIS THE ZYRIS ORGANIZATION LTD.
1866328 03 Nov 2017 | on 18 May 2021 | Class 042 Class 042 Computer & Software Services & Scientific Services Technological research and development in the field of computer hardware and software; design and development of computer hardware and software | | | ZYLEXIS PFIZER INC.
1410054 09 Sep 2008 | on 28 Sep 2011 | Class 005 Class 005 Pharmaceutical Products Veterinary preparations and substances for the prevention or treatment of ocular disorders; oral diseases; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, insomnia, seizure disorders; circulatory system diseases and disorders, namely disorders in blood circulation, hypertension, portal hypertension, pulmonary diseases, pulmonary hypertension and heart failure; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; the cardio-vascular system; the respiratory system; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; the digestive system; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and reproductive health diseases and disorders, namely, male and female infertility, ovulation disorders, hormone replacement therapy indicated for the relief of menopause symptoms and the prevention of osteoporosis; veterinary preparations and substances for the treatment or prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations and substances for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; veterinary preparations and substances, namely, dental preparations, namely a pharmaceutical drug or vaccine for the treatment or prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; veterinary preparations and substances, namely, nutritional additives to foodstuffs for animals for medical purposes and food supplements; veterinary preparations and substances, namely, pharmaceutical preparations for relieving teething pains and toothaches in companion animals; veterinary parasiticides; veterinary analgesic preparations; veterinary anti-allergen preparations, namely, allergy medications; veterinary preparations and substances, namely, anti-infectives, anti-bacterials, anti-virals, antibiotics, antifungals, anthelmintics, all of the foregoing for treating felines, canines, bovines, porcines, equines, rabbits, poultry, goats and sheep. | | | ZYMOGENESIS THE SYNERGY COMPANY OF UTAH LLC
1365561 28 Sep 2007 | on 23 May 2024 | Class 005 Class 005 Pharmaceutical Products Nutritional supplements namely fermented and probiotic digestive enzymes | | | ZYKIS ZYKIS LLC A LIMITED LIABILITY COMPANY DULY ORGANIZED AND EXISTING UNDER THE LAWS OF THE STATE OF CALIFORNIA
1345863 02 May 2007 | on 31 Jul 2012 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software. Class 042 Class 042 Computer & Software Services & Scientific Services Computer services; search engine services; search engine services provided over a global computer network directed to family and children-oriented content. | | | ZYLEXIS PHARMACIA & UPJOHN COMPANY LLC
(A DELAWARE LIMITED LIABILITY COMPANY)
1153906 26 Sep 2002 | on 03 Jun 2009 | Class 005 Class 005 Pharmaceutical Products Veterinary pharmaceutical, namely, an immunological preparation for the prevention and metaphylaxis of infections and stress-induced diseases. | | | ZYNTHIS PFIZER PRODUCTS INC.
(A CONNECTICUT CORPORATION)
1095489 09 Mar 2001 | on 25 Jan 2002 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical products, namely, cardiovascular preparations. | | | ZYNAXIS ZYNAXIS INC.
A PENNSYLVANIA CORPORATION
737425 22 Sep 1993 | on 31 Dec 1969 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Cell linker material for clinical and research use. | | | ZYDIS R.P. SCHERER TECHNOLOGIES INC.
629357 13 Apr 1989 | on 04 Jan 1991 | Class 005 Class 005 Pharmaceutical Products Fast dissolving, orally administered dosage form for drugs, vitamins, and dietary supplements, for both human and veterinary use. | |